Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Make Peace with Complexity

David S. Pisetsky, MD, PhD  |  Issue: May 2007  |  May 1, 2007

David S. Pisetsky, MD, PhD

Several years ago, at a venerable New York hotel, I attended a meeting that has made a lasting impression on my thinking. The purpose of the event was to bring together academic physicians of all levels for two days of lectures, dinners, and talk. On the first afternoon, we had breakout sessions to discuss topics of major, even pretentious-sounding, importance: the future of clinical research, the health of the Third World, the genetic revolution. The breakout groups comprised everyone from a post-doc to a professor and featured an eclectic mix of sub-specialties, all sitting around tables in darkened meeting rooms that were oppressively overheated.

The breakout groups were charged with reducing our deliberations into a key concept to guide future clinical or basic research, policymaking, or even a personal career choice. Although the groups focused on different subjects and had amazingly diverse memberships, we all came back with the same word. That key word was (drum roll, please) complexity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

You may find it ironic that complexity could be a simplifying concept but the unanimity of its selection shows how complicated medicine has become.

As Simple as Complexity

Everything about modern medicine is complicated. I love adjectives, so I suggest the following other descriptors of our current state: multifaceted, convoluted, intertwined, interdependent, interdigitated, intricate, thorny, and downright confusing. Nothing in research is simple anymore. Clinical trials can number 50,000 patients and—with mathematic and statistical analyses worthy of astrophysics—provide evidence for 1.1 relative risk of an adverse event that occurs in one in a thousand subjects. Genetic studies are similarly baroque, involving hundreds of SNPs distributed unevenly in the population but, in certain alignments (or phases of the moon), produce a suggestion that genes do matter after all. Microarray analyses are even worse because, in reality, each data point comprises myriad others.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Clinical medicine can be similarly dizzying in its practice. Each decision involves a measured and deliberate weighing of risks and benefits, which must be explained in a comprehensible way to the patient even though the physician might be clueless about the right choice. The problem is that the risks and benefits are often uncertain, shifting, or imprecise. While, as professionals, we pride ourselves for being evidence based, often the evidence simply does not exist.

Our breakout groups were correct. Complexity governs our work as physicians and providers.

No More Easy Decisions

As noted in “Sniff 101 and Other Lessons” (April 2007, pg. 6), I recently attended on general medicine and was amazed by the complexity of the medical problems I saw and the tortuous thought process necessary to devise even the most basic diagnostic or therapeutic plan. Modern medicine is now like a chess game; we have to plan for many moves in advance knowing that our opponent, sickness, is cagey, mean, and unpredictable. How do you play chess against a madman, knowing that erratic moves can beat even the cleverest strategy?

Page: 1 2 3 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:Medical decision makingrheumatologist

Related Articles

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

    Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

    November 10, 2021

    Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2021.

    New Gout Criteria from the ACR/EULAR Focus on Clinical Trials, Global Standards

    November 17, 2015

    Gout affects nearly 4% of American adults, causing joint inflammation, pain and crystal deposits that may lead to bone erosion over time. At least five different classification criteria for gout are used worldwide, creating potential discrepancies in clinical trial enrollment and eventual results. An international panel of investigators collaborated to create new, standardized gout classification…

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences